Back to Search
Start Over
Synergistic effects of quorum-sensing molecules and antimicrobials against Candida albicans and Pseudomonas aeruginosa biofilms: in vitro and in vivo studies.
- Source :
-
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Nov 04; Vol. 79 (11), pp. 2828-2836. - Publication Year :
- 2024
-
Abstract
- Background: Candida albicans can form polymicrobial biofilms with other microorganisms, such as Pseudomonas aeruginosa, at infection sites.<br />Objectives: As biofilms are highly resistant to antibiotics there is a need for new antibiofilm agents that have unique targets and modes of action.<br />Methods: In this study the antibiofilm effects of two quorum-sensing molecules (QSMs), farnesol and tyrosol, were investigated alone and in combination with antibiotics (aztreonam, colistin, tobramycin) and antifungals (fluconazole, amphotericin B, caspofungin), against single- and dual-species biofilms of C. albicans and P. aeruginosa in in vitro and in vivo systems.<br />Results: It was observed that QSMs alone, especially farnesol, showed at least a 1-log reduction against preformed single- and dual-species biofilms of C. albicans and P. aeruginosa. Combination of QSMs with colistin or fluconazole was found to be effective against both single- and dual-species biofilms in vitro. Increased survival was observed in C. elegans when treated with colistin or fluconazole in combination with QSMs, compared with no treatment. Additionally, the QSMs and colistin and farnesol combinations effectively inhibited biofilm formation by C. albicans and P. aeruginosa on bronchial epithelial cells, and reduced IL-1β expression in lung bronchial epithelial cells.<br />Conclusions: There is a need for effective treatments for bacterial-fungal biofilm infections and, to our knowledge, there have been no studies of QSMs and antimicrobial combinations against dual-species biofilms involving C. albicans and P. aeruginosa. Hence these findings will make a significant contribution to the literature.<br /> (© The Author(s) 2024. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
- Subjects :
- Animals
Phenylethyl Alcohol pharmacology
Phenylethyl Alcohol analogs & derivatives
Anti-Bacterial Agents pharmacology
Pseudomonas Infections drug therapy
Pseudomonas Infections microbiology
Antifungal Agents pharmacology
Microbial Sensitivity Tests
Humans
Microbial Viability drug effects
Mice
Biofilms drug effects
Pseudomonas aeruginosa drug effects
Pseudomonas aeruginosa physiology
Candida albicans drug effects
Candida albicans physiology
Quorum Sensing drug effects
Drug Synergism
Caenorhabditis elegans microbiology
Caenorhabditis elegans drug effects
Farnesol pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1460-2091
- Volume :
- 79
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- The Journal of antimicrobial chemotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 39212125
- Full Text :
- https://doi.org/10.1093/jac/dkae293